Table 2 Relationship between maternal polygenic risk scores and preeclampsia onset in the maternal cohorts by logistic regression analysis.
Internal validation cohort | External validation cohort | Meta-analysis | |||||
---|---|---|---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | P for heterogeneity | |
PRS for SBP | |||||||
Continuous | 1.01 (0.91 to 1.13) | 0.794 | 1.33 (1.17 to 1.50) | < 0.001 | 1.14 (1.05 to 1.24) | 0.002 | 0.001 |
Tertile 1 | Reference | Reference | Reference | ||||
Tertile 2 | 1.09 (0.83 to 1.44) | 0.532 | 1.02 (0.76 to 1.39) | 0.874 | 1.06 (0.86 to 1.30) | 0.570 | 0.761 |
Tertile 3 | 0.96 (0.73 to 1.26) | 0.768 | 1.61 (1.21 to 2.16) | 0.001 | 1.22 (1.00 to 1.49) | 0.046 | 0.010 |
PRS for DBP | |||||||
Continuous | 1.08 (0.96 to 1.21) | 0.186 | 1.39 (1.22 to 1.58) | < 0.001 | 1.20 (1.11 to 1.31) | < 0.001 | 0.003 |
Tertile 1 | Reference | Reference | Reference | ||||
Tertile 2 | 0.80 (0.59 to 1.08) | 0.150 | 1.33 (0.98 to 1.79) | 0.063 | 1.03 (0.84 to 1.28) | 0.768 | 0.020 |
Tertile 3 | 1.05 (0.80 to 1.37) | 0.748 | 2.18 (1.62 to 2.94) | < 0.001 | 1.46 (1.19 to 1.78) | < 0.001 | 0.000 |
PRS for PE | |||||||
Continuous | 1.01 (0.91 to 1.13) | 0.817 | 1.21 (1.07 to 1.37) | 0.002 | 1.10 (1.01 to 1.19) | 0.026 | 0.030 |
Tertile 1 | Reference | Reference | Reference | ||||
Tertile 2 | 1.05 (0.81 to 1.35) | 0.705 | 1.34 (0.96 to 1.88) | 0.085 | 1.15 (0.94 to 1.41) | 0.179 | 0.252 |
Tertile 3 | 1.04 (0.79 to 1.36) | 0.792 | 1.49 (1.08 to 2.05) | 0.014 | 1.20 (0.98 to 1.48) | 0.076 | 0.087 |